India's Pharmaceutical Export Boom: Staying Strong Amid Global Challenges

Indian pharmaceutical exports grew by 5% reaching nearly USD 29 billion, as of February this financial year, despite global challenges. The sector aims to reach USD 130 billion by 2030. Exports are driven by formulations, biologicals, vaccines, and Ayush products, showcasing resilience despite pricing pressures.

India's pharmaceutical export sector showcased robust growth, standing at nearly USD 29 billion up to February, marking a 5% increase compared to the previous year.

K Raja Bhanu, Director General of PHARMEXCIL, highlighted the sector's resilience, attributing growth to formulations, biologicals, vaccines, and Ayush products despite international pricing pressures.

Projected to reach USD 130 billion by 2030, the sector managed to achieve USD 30.47 billion in FY 2024–25, with a 9.4% growth, despite global trade volatilities.

(With inputs from agencies.)